Arch Therapeutics Inc (OTCQB:ARTH)

0.041
Delayed Data
As of Aug 15
 -0.0045 / -9.89%
Today’s Change
0.04
Today|||52-Week Range
0.14
-56.84%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Arch Therapeutics Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +7,217.07% increase from the last price of 0.04.

Chart unavailable

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Arch Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.01
Sales
$0.00
Reporting Date
Aug 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually 0.00%
 
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.